AI assistant
Pfizer Ltd. — Regulatory Filings 2022
Jun 3, 2022
60507_rns_2022-06-03_32b7fa18-974c-48ff-9f9e-09a28f56d6f1.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
Pfizer Limited The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274
==> picture [94 x 39] intentionally omitted <==
June 3, 2022
The Corporate Relationship Dept. BSE Limited 1[st] Floor, P.J.Towers Dalal Street, Fort Mumbai - 400 001 Scrip Code: 500680
The Manager, Listing Dept. The National Stock Exchange of India Ltd. Exchange Plaza, 5[th] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Scrip Symbol: PFIZER
Dear Sirs,
Sub: Disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)
Pursuant to Regulation 23(9) of the Listing Regulations, please find enclosed, disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended March 31, 2022.
The said disclosure is also available on the website of the Company i.e., www.pfizerindia.com
Please take the above on record.
Thanking you,
Yours truly,
For Pfizer Limited
==> picture [105 x 52] intentionally omitted <==
Prajeet Nair Company Secretary
Encl: A/a
CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerindia.com
Pfizer Limited - Statement of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015
| Additional disclosure of related party transactions - applicable only in case the related party transaction relates to corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to b once, during the reporting period when such transaction was undertaken. |
Additional disclosure of related party transactions - applicable only in case the related party transaction relates to corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to b once, during the reporting period when such transaction was undertaken. |
Additional disclosure of related party transactions - applicable only in case the related party transaction relates to corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to b once, during the reporting period when such transaction was undertaken. |
Additional disclosure of related party transactions - applicable only in case the related party transaction relates to corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to b once, during the reporting period when such transaction was undertaken. |
Additional disclosure of related party transactions - applicable only in case the related party transaction relates to corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to b once, during the reporting period when such transaction was undertaken. |
Additional disclosure of related party transactions - applicable only in case the related party transaction relates to corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to b once, during the reporting period when such transaction was undertaken. |
Additional disclosure of related party transactions - applicable only in case the related party transaction relates to corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to b once, during the reporting period when such transaction was undertaken. |
loans, inter- e disclosed only |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sr. no | Details of the party listedentity entering into the transaction |
Details of the counter party | Type of related party transaction | Value of the related party transaction as approved by the audit committee |
Value of transaction during the reporting period |
In case monies are due to either party as a result of the transaction |
In case any financial indebtedness is incurred to make or give loans, inter- corporate deposits, advances or investments |
Details of the loans, inter-corporate deposits, advances or investments | ||||||||||
| Name | PAN | Name | PAN | Relationship of the counterparty with the listed entity or its subsidiary |
Opening balance | Closing balance | Nature of indebtedness (loan/ issuance of debt/ any other etc.) |
Cost | Tenure | Nature (loan/ advance/ inter- corporate deposit/ investment |
Interest Rate (%) |
Tenure | Secured/ unsecured |
Purpose for which the funds will be utilised by the ultimate recipient of funds (end- usage) |
||||
| 1 | Pfizer Limited | AAACP3334M | Pfizer Service Company BVBA, Belgium | ZZZZZ9999Z | Fellow subsidiary | Purchase of goods & services | 2382833671 | 2382833671 | 1087197523 | 815975390.7 | Not Applicable | |||||||
| 2 | Pfizer Limited | AAACP3334M | John Wyeth & Brother Limited | AAACJ1732F | Company collectively exercising significant influence |
Recovery of expense | 633166 | 633166 | 24397725 | 24388559 | Not Applicable | |||||||
| 3 | Pfizer Limited | AAACP3334M | Pfizer Healthcare India Private Limited | AABCO2190F | Fellow subsidiary | Reimbursement of expense | 57388608 | 57388608 | 0 | 57385307 | Not Applicable | |||||||
| 4 | Pfizer Limited | AAACP3334M | Pfizer Products India Private Limited | AADCP8985B | Fellow subsidiary | Service income | 99376608 | 99376608 | -50631379.28 | -38972161.52 | Not Applicable | |||||||
| 5 | Pfizer Limited | AAACP3334M | Pfizer Products India Private Limited | AADCP8985B | Fellow subsidiary | Recovery of expense | 12499233 | 12499233 | 0 | 0 | Not Applicable | |||||||
| 6 | Pfizer Limited | AAACP3334M | Pfizer Overseas LLC | ZZZZZ9999Z | Fellow subsidiary | Service income | 27063952.9 | 27063952.9 | -28727487.26 | 3496591 | Not Applicable | |||||||
| 7 | Pfizer Limited | AAACP3334M | Pfizer Export B.V. | ZZZZZ9999Z | Fellow subsidiary | Service Income | 20350197 | 20350197 | -12202813.25 | -20458076.24 | Not Applicable | |||||||
| 8 | Pfizer Limited | AAACP3334M | Medybiz Pharma Private Limited | AAGCM2841J | Entity wherein Director is an interested party |
Service fee | 816480 | 816480 | 0 | 0 | Not Applicable | |||||||
| 9 | Pfizer Limited | AAACP3334M | Healthvista India Private Limited | AADCH1849J | Entity wherein Director is an interested party |
Service fee | 2437980 | 2437980 | 0 | 0 | Not Applicable | |||||||
| 10 | Pfizer Limited | AAACP3334M | Pfizer Investment Co.ltd | ZZZZZ9999Z | Fellow subsidiary | Export of finished goods | 12174960.00 | 12174960.00 | 0 | -12174960 | Not Applicable | |||||||
| 11 | Pfizer Limited | AAACP3334M | Crawford Bayley | AAAFC0787E | Entity wherein Director is an interested party |
Service fee | 4779850 | 4779850 | 0 | 0 | Not Applicable | |||||||
| 12 | Pfizer Limited | AAACP3334M | Pfizer Worldwide Services Company | ZZZZZ9999Z | Fellow subsidiary | Service income | 295988229 | 295988229 | -136404760.6 | -130304592.3 | Not Applicable |